Michael Mason's Net Worth
$8.29 Million
Who is Michael Mason?
Michael Mason has an estimated net worth of $8.29 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., and Karyopharm Therapeutics Inc..
SEC CIK
Michael Mason's CIK is 0001514291
Past Insider Trading and Trends
2018 was Michael Mason's most active year for acquiring shares with 18 total transactions. Michael Mason's most active month to acquire stocks was the month of November. 2013 was Michael Mason's most active year for disposing of shares, totalling 20 transactions. Michael Mason's most active month to dispose stocks was the month of November. 2018 saw Michael Mason paying a total of $2,804,910.51 for 46,246 shares, this is the most they've acquired in one year. In 2018 Michael Mason cashed out on 68,975 shares for a total of $4,876,007.21, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $168.975
VP, Finance and Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 21
| |||
Form 4
| +271.24% | 613 |
$90.95 | -$40,836.55 | 839 |
Jan 17 - Aug 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| -100.00% | -4.96K |
$109.93 | -$2,030,260.15 |
0
|
Scheduled
|
Jan 4
| ||
Form 4
|
∞
| 4.96K |
$127.05 | -$449,502.90 | 4.96K |
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 4
|
—
|
0
|
$42.02 | -$524,662.50 |
0
|
Scheduled
|
May 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
$88.94 | -$411,120.65 |
0
|
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| -100.00% | -1.54K |
$54.50 | -$1,923,691.88 |
0
|
Scheduled
|
Dec 12 - Dec 15
| ||
Form 4
| -70.93% | -3.75K |
$78.66 | -$294,992.48 | 1.54K |
Scheduled
|
Feb 3
| ||
Form 4
| -32.62% | -2.56K |
$89.49 | -$229,094.40 | 5.29K |
Jan 23
| |||
Form 4
|
—
|
0
|
$36.46 | -$382,362.38 | 7.85K |
Scheduled
|
Dec 16 - Dec 18
| ||
Form 4
|
—
|
0
|
$34.46 | -$205,237.63 | 7.85K |
Scheduled
|
Dec 2
| ||
Form 4
|
—
|
0
|
$40.70 | -$264,262.00 | 7.85K |
Scheduled
|
Jul 12
| ||
Form 4
|
—
|
0
|
$27.07 | -$266,550.00 | 7.85K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$21.79 | -$384,957.54 | 7.85K |
Scheduled
|
Jun 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
$12.02 | -$36,847.12 | 7.85K |
Scheduled
|
Nov 30
| ||
Form 4
|
—
|
0
|
$15.49 | -$56,375.00 | 7.85K |
Scheduled
|
Jul 27
| ||
Form 4
|
—
|
0
|
$14.99 | -$109,489.36 | 7.85K |
Scheduled
|
Jul 16
| ||
Form 4
|
∞
| 7.85K |
—
|
—
| 7.85K |
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Karyopharm Therapeutics Inc. (KPTI) Snapshot price: $1.525
EVP, CFO & Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.82% | -33.85K |
$1.18 | -$39,788.19 | 398.76K |
Feb 29 - Mar 1
| |||
Form 4
| +75.18% | 185.66K |
$1.32 | -$3,369.07 | 432.61K |
Feb 27 - Feb 28
| |||
Form 4
| -1.67% | -4.21K |
$1.59 | -$6,671.23 | 246.94K |
Feb 6
| |||
Form 4
| +5.61% | 13.33K |
—
|
—
| 251.15K |
Jan 24
| |||
Form 4
| -2.82% | -6.91K |
$1.33 | -$9,203.28 | 237.82K |
Sep 1
| |||
Form 4
| -0.26% | -631.00 |
$2.22 | -$1,400.82 | 244.73K |
Jun 2
| |||
Form 4
| +51.86% | 83.8K |
$3.03 | -$33,942.19 | 245.36K |
Feb 28 - Mar 1
| |||
Form 4
| -1.70% | -2.80K |
$3.04 | -$8,509.11 | 161.57K |
Feb 27
| |||
Form 4
| -2.46% | -4.14K |
$3.40 | -$14,079.40 | 164.37K |
Feb 6
| |||
Form 4
| +21.66% | 30K |
—
|
—
| 168.51K |
Aug 31
| |||
Form 4
| -0.43% | -601.00 |
$6.04 | -$3,630.12 | 138.51K |
Jun 3
| |||
Form 4
| +160.96% | 85.8K |
$10.24 | -$24,549.52 | 139.11K |
Feb 28
| |||
Form 4
| -6.89% | -3.95K |
$9.86 | -$38,925.31 | 53.31K |
Feb 7
| |||
Form 4
| +10.63% | 5.5K |
—
|
—
| 57.26K |
Jun 1
| |||
Form 4
| +74.01% | 22.01K |
—
|
—
| 51.76K |
Feb 25
| |||
Form 4
| -35.07% | -2.86K |
$15.52 | -$44,353.59 | 5.29K |
Feb 11
| |||
Form 4
|
∞
| 8.15K |
—
|
—
| 8.15K |
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||